CONFRONTING PICTURE OF GROWING WOMEN’S HEALTH CRISIS IN UTERINE CANCERS. ANZGOG State of the Nation report highlights inequities in uterine cancer outcomes across Australia
With
Associate Professor Yoland Antill, Director and Deputy Chair, Australia New Zealand Gynaecological Oncology Group (ANZGOG)
SEGMENT
Filmed in Melbourne | December 2025
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
Once considered a cancer that primarily affected older women, the report highlights an alarming new trend: incidence is now rising fastest among women aged 25 to 44, with cases in this age group expected to increase by around 60 per cent alone, over the next decade.
Despite its growing impact, uterine cancer remains largely invisible in Australia’s cancer conversation. The limited research available notes, 94 per cent of women are unaware of what uterine or endometrial cancers are yet increased awareness of the disease and risk factors could prevent up to 60 per cent of future diagnoses. Research investment for uterine cancers lags far behind other cancers.
In addition, support and psychosocial care for women living with uterine cancers are inconsistent, and currently there is no dedicated national advocacy organisation. Many women face pain, fatigue, anxiety and long-term side effects alone.
State of the Nation report sets out a national plan to reverse the rise in uterine cancers and transform outcomes for Australian women
The report identifies five urgent priorities: halve incidence, eliminate inequities, ensure access to precision care, support every woman to live well, and invest in research and data. Achieving these goals will require united action from government, researchers, clinicians, industry and the community to deliver the innovation, equity and support Australian women deserve.
Source: Adapted from ANZGOG media release November 2025
Report: ANZGOG State of the Nation Report into Uterine Cancers can be read here https://www.anzgog.org.au/sotn-uterine-cancer, prepared by Insight Economics
You Might also like
-
Physiotherapist, exercise physiologist support for management of osteoporosis
Osteoporosis is commonly managed medically and typically with treatment. Exercise is also essential in the management of osteoporosis but tends to be under-utilised due to lack of knowledge and unfounded concerns about the risk of injury. In fact, optimal care of people with low bone mass, osteoporosis and/or increased risk of falling can and should include targeted exercise to help prevent osteoporotic fracture.
In early 2024, Healthy Bones Australia released a summary of the principles of osteogenic loading and fall prevention, the translation of those principles into clinical practice, evidence-based recommendations for exercise prescription, and special considerations, along with links to several relevant resources for people with or at risk of osteoporosis, falls and fractures.
-
Smart technology in wound care
Throughout her journey around wound care, Santosh Kaur was frustrated to see the simple gaps in wound care resulting in negative patient outcomes. Santosh is the founder of SmartHeal which launched in 2020.
SmartHeal replaces the nurses taking cumbersome manual measurements and manual sharing of important wound data with a no touch technique. It aims for healthcare professionals to have live remote access to wound data, make wound assessments and assist with speech to text notes thus saving time, cost and people. SmartHeal also aims to assist healthcare professionals in providing optimum wound care by analysing the wound tissue for infection, moisture and providing suggestions for suitable dressing.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.